Inotiv, Inc.(NOTVQ)
Life Sciences Tools & Services
Preclinical & Toxicology Services
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | Leasure Robert Jr. President and CEO | Sale | -16,810 | -1.94%847,680 | $0.30 | $4,964 | View SEC filing | |
| 2026-02-19 | Sagartz John E Chief Strategy Officer | Sale | -2,119 | -0.31%676,197 | $0.29 | $616 | View SEC filing | |
| 2026-02-19 | Taylor Beth A. Chief Financial Officer | Sale | -2,888 | -3.86%71,980 | $0.29 | $846 | View SEC filing | |
| 2026-02-03 | Leasure Robert Jr. President and CEO | Sale | -113,297 | -11.59%864,490 | $0.50 | $57,034 | View SEC filing | |
| 2025-12-02 | Neff R Matthew Director | Sale | -2,000 | -2.08%94,210 | $0.89 | $1,771 | View SEC filing | |
| 2025-11-04 | Neff R Matthew Director | Sale | -2,000 | -2.04%96,210 | $1.24 | $2,487 | View SEC filing | |
| 2025-10-03 | Neff R Matthew Director | Sale | -2,000 | -2.00%98,210 | $1.43 | $2,858 | View SEC filing | |
| 2025-09-04 | Neff R Matthew Director | Sale | -2,000 | -1.96%100,210 | $1.67 | $3,338 | View SEC filing | |
| 2025-08-04 | Neff R Matthew Director | Sale | -2,000 | -1.92%102,210 | $1.91 | $3,818 | View SEC filing | |
| 2025-07-03 | Neff R Matthew Director | Sale | -2,000 | -1.88%104,210 | $1.81 | $3,621 | View SEC filing | |
| 2025-06-04 | Neff R Matthew Director | Sale | -2,000 | -1.85%106,210 | $2.62 | $5,246 | View SEC filing | |
| 2025-04-02 | Coelho Mary Theresa Director | Sale | -5,500 | -42.60%7,411 | $2.35 | $12,916 | View SEC filing | |
| 2025-02-20 | Freeman Jeffrey Brennan VP-Finance & Corp. Controller | Sale | -1,339 | -4.65%27,478 | $4.04 | $5,416 | View SEC filing | |
| 2025-02-20 | Taylor Beth Chief Financial Officer | Sale | -4,370 | -5.52%74,868 | $4.01 | $17,507 | View SEC filing | |
| 2025-02-20 | Sagartz John E Chief Strategy Officer | Sale | -2,113 | -0.31%678,316 | $3.94 | $8,316 | View SEC filing | |
| 2025-02-20 | Leasure Robert Jr. President and CEO | Sale | -73,617 | -7.00%977,787 | $3.82 | $281,136 | View SEC filing | |
| 2025-02-04 | Leasure Robert Jr. President and CEO | Sale | -22,700 | -2.11%1,051,404 | $4.15 | $94,298 | View SEC filing | |
| 2025-02-04 | Taylor Beth Chief Financial Officer | Sale | -2,054 | -2.53%79,238 | $4.46 | $9,171 | View SEC filing | |
| 2025-02-04 | Sagartz John E Chief Strategy Officer | Sale | -2,118 | -0.31%680,429 | $4.48 | $9,479 | View SEC filing | |
| 2025-02-04 | Krupp Jeffrey Arthur Chief Human Resources Officer | Sale | -2,508 | -8.07%28,557 | $4.42 | $11,096 | View SEC filing | |
| 2024-12-23 | Landman David Director | Purchase | +23,529 | +15.35%176,851 | $4.25 | $99,998 | View SEC filing | |
| 2024-12-12 | Beattie John Gregory Chief Operating Officer | Purchase | +30,000 | +22.77%161,761 | $4.75 | $142,500 | View SEC filing | |
| 2024-12-10 | Brown Nigel Director | Purchase | +7,500 | +12.92%65,537 | $4.26 | $31,950 | View SEC filing | |
| 2024-12-10 | Harrington Michael J Director | Purchase | +10,000 | +36.36%37,500 | $3.98 | $39,822 | View SEC filing | |
| 2024-12-10 | Landman David Director | Purchase | +100,000 | +187.54%153,322 | $4.14 | $414,000 | View SEC filing |
1-25 of 141